Free Trial
ASX:PME

Pro Medicus (PME) Stock Price, News & Analysis

Pro Medicus logo

About Pro Medicus Stock (ASX:PME)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
285,954 shs
Average Volume
N/A
Market Capitalization
A$29.16 billion
P/E Ratio
351.99
Dividend Yield
0.14%
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive PME Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Pro Medicus and its competitors with MarketBeat's FREE daily newsletter.

PME Stock News Headlines

Alex’s “Next Magnificent Seven” stocks
The original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Magnificent Seven—seven stocks he believes could deliver similar gains in under six years. His full breakdown is now live.
Pro Medicus Secures $20M Contract Renewal with FMOLHS
PME - Pro Medicus Ltd Key Metrics - Morningstar
See More Headlines

PME Stock Analysis - Frequently Asked Questions

Based on aggregate information from My MarketBeat watchlists, some other companies that Pro Medicus investors own include Mineral Resources (MIN), ResMed (RMD), Technology One (TNE), ARB (ARB), Accent Group (AX1), Cochlear (COH) and CSL (CSL).

Industry, Sector and Symbol

Stock Exchange
ASX
Sector
Medical
Industry
Health Information Services
Sub-Industry
N/A
Current Symbol
ASX:PME
CIK
N/A
Fax
N/A
Employees
2,060
Year Founded
N/A

Profitability

EPS (Trailing Twelve Months)
A$0.78
Trailing P/E Ratio
351.99
Forward P/E Ratio
N/A
P/E Growth
3.87
Net Income
A$82.79 million
Net Margins
51.27%
Pretax Margin
N/A
Return on Equity
47.73%
Return on Assets
30.68%

Debt

Debt-to-Equity Ratio
1.10
Current Ratio
5.98
Quick Ratio
4.39

Sales & Book Value

Annual Sales
A$161.50 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
71.76
Book Value
A$1.80 per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
104,500,000
Free Float
N/A
Market Cap
A$29.16 billion
Optionable
Not Optionable
Beta
0.56
Analysts Agree—These Gold Picks Outshine the Rest Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (ASX:PME) was last updated on 8/7/2025 by MarketBeat.com Staff
From Our Partners